Delcath Systems, Inc. (DCTH) — Stock Score Summary

Delcath Systems, Inc. (DCTH) has a MoatMap StockRank of 86/100 based on Quality (71/100), Value (46/100), and Momentum (55/100) factor scores. The current signal is STRONG BUY. Delcath Systems is a micro-cap medical device/biotech company with binary regulatory and commercialization risks, failing our requirement for established quality compounders with high ROIC.

Delcath Systems, Inc. is a commercial-stage oncology company focused on developing and commercializing its proprietary Melphalan Hepatic Delivery System (Melphalan/HDS) for treating primary and metastatic cancers of the liver. The company's unique drug-device combination allows for targeted regional chemotherapy, offering a specialized treatment option for liver-dominant cancers with reduced systemic toxicity.

Key Financial Metrics

Price$11.69
Market Cap$378M
P/E (TTM)1079.00
P/E (Forward)-28.15
Price/Book3.30
Return on Equity0.6%
Return on Invested Capital0.6%
Debt/Equity0.81
Gross Margin86.0%
Operating Margin-6.6%
Revenue Growth26.3%
Free Cash Flow$20M

Delcath Systems, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Delcath Systems, Inc.’s (DCTH) StockRank?
MoatMap’s StockRank for Delcath Systems, Inc. (DCTH) is 86/100, with a Strong Buy signal. It is a composite of Quality (71), Value (46), and Momentum (55) factor ranks across MoatMap’s 19,000+ stock universe.
Does Delcath Systems, Inc. have an economic moat?
Delcath Systems, Inc. (DCTH) has a Quality factor score of 71/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Delcath Systems, Inc. a buy, hold, or sell?
MoatMap’s current signal for Delcath Systems, Inc. (DCTH) is Strong Buy, based on a StockRank of 86/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Delcath Systems, Inc. in?
Delcath Systems, Inc. (DCTH) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksDCTH deep dive reportAI ChampionsHow we score stocksSense-check another stock